Increased interleukin-4 production by CD8 and γδ T cells in health-care workers is associated with the subsequent development of active tuberculosis

Journal of Infectious Diseases

Volumn 190, Issue 4, 2004, Pages 756-766

  Ordway, Diane J ^a,b,f   Costa, Leonor ^a   Martins, Marta ^a   Silveira, Henrique ^a   Amaral, Leonard ^a   Arroz, Maria J ^a,b,c   Ventura, Fernando A ^a,b,c,d   Dockrell, Hazel M ^e  

^a UNIVERSITY OF LISBON   (Portugal)

^b HOSPITAL EGAS MONIZ   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d Comissao Nac de Luta Contra a Sida ^*  (Portugal)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEALTH CARE PERSONNEL; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DELIVERY OF HEALTH CARE; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; MYCOBACTERIUM TUBERCULOSIS; PORTUGAL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SPECIES SPECIFICITY; TUBERCULOSIS;

EID: 3943106044     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/422532     Document Type: Article

References (65)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282:677-86.
2. Grange JM, Zumla A. The global emergency of tuberculosis: what is the cause? J R Soc Health 2002; 122:78-81.
3. Direcçāo Geral de Saúde. Tuberculose em Portugal, 1993. Lisbon: Direcção Geral de Saúde, 1994.
4. Raviglione MC, Rieder HL, Styblo K, Khomenko AG, Esteves K, Kochi A. Tuberculosis trends in eastern Europe and the former USSR. Tubercle Lung Dis 1994; 75:400-16.
5. Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in western Europe. Bull WHO 1993; 71:297-306.
6. Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB. Tuberculosis control subjects in Europe and international migration. Eur Respir J 1994; 7:1545-53.
7. Do AN, Limpakarnjarat K, Uthaivoravit W, et al. Increased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand. Int J Tuberc Lung Dis 1999; 3:377-81.
8. Wilkinson D, Crump J, Pillay M, Sturm AW. Nosocomial transmission of tuberculosis in Africa documented by restriction fragment length polymorphism [case report]. Trans R Soc Trop Med Hyg 1997; 91:318.
9. Harris AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. High death rates in health care workers and teachers in Malawi. Trans R Soc Trop Med Hyg 2002; 96:34-7.
10. Silva VMC, Cunha AJ, Oliveira JR, et al. Medical students at risk of nosocomial transmission of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2000; 4:420-6.
11. Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 1995; 122:90-5.
12. Alonso-Echanove J, Granich RM, Laszlo A, et al. Occupational transmission of Mycobacterium tuberculosis to health care workers in a university hospital in Lima, Peru. Clin Infect Dis 2001; 33:589-96.
13. Biscaia A, Conceicao C, Martins J, Ferrinho P. Associacao para o desenvolvimento e cooperacao garcia de orta. Cah Sociol Demogr Med 2003; 43:379-96.
14. Vieira J, Vanzeller M, Forte MJ, Brito MC, Duarte R, Sapage JM. Tuberculose nos profissionais de saude. Rev Port Pneumol 2002; 1:97.
15. Portugal I, Covas MJ, Brum L, et al. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 1999; 3:207-13.
16. Hannan MM, Peres H, Maltez F, et al. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect 2001; 47:91-7.
17. Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982; 125:8-15.
18. Collins FM, Congdon CC, Morrison NE. Growth of Mycobacterium bovis (BCG) in T lymphocyte-depleted mice. Infect Immun 1975; 11:57-64.
19. Ladel CH, Hess J, Daugelat P, Mombaerts P, Tonegawa S, Kaufmann SH. Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: studies with T cell receptor deficient mutant mice. Eur J Immunol 1995; 25:838-46.
20. Boom WH. The role of T-cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis 1996; 5:73-81.
21. Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993; 11:129-63.
22. North RJ. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol 1973; 7:166-76.
23. Orme IM, Andersen P, Boom WH. T cell responses to Mycobacterium tuberculosis. J Infect Dis 1993; 167:1481-97.
24. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89:12013-7.
25. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243-7.
26. Flynn JL, Chan J, Triebold KJ, Dalton SK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
27. Kamijo RJ, Le Shapiro D, Havell EA, et al. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178:1435-40.
28. Kumararatne DS. Tuberculosis and immunodeficiency - of mice and men. Clin Exp Immunol 1997; 107:11-4.
29. Hoft DF, Worku S, Kampmann B, et al. Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity. J Infect Dis 2002; 186:1448-57.
30. Ho JL, He SH, Rio MJ, Wick EA. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J Infect Dis 1992; 165:344-51.
31. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR. IL-4 inhibits IL-2 receptor expression and IL-2 dependant cell proliferation of human T cells. J Immunol 1990; 144:2211-5.
32. Jankovic D, Liu Z, Gause WC. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 2001; 22:450-7.
33. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
34. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76:241-51.
35. Bhattacharyya SR, Singla R, Dey AB, Prasad HK. Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun 1999; 67:5597-603.
36. + T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis (Edinb) 2002; 82:7-13.
37. Das G, Vorha B, Saha B, Agrewala JN, Mishra GC. Apoptosis of Th1-like cells in experimental tuberculosis (TB). Clin Exp Immunol 1999; 115:324-8.
38. Johnson BJ, McMurray DN. Cytokine gene expression by culture of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes. Infect Immun 1994; 62:1444-50.
39. Sanchez FO, Rodriguez JI, Agudelo G, Garcia LF. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy control subjects. Infect Immun 1994; 62:5673-8.
40. Zhang MJ, Gong DH, Presky DH, Xue W, Barnes PF. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol 1999; 162:2441-7.
41. + T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000; 181:1194-7.
42. Antunes Mde L. Tuberculose em Portugal. Acta Med Port 1995; 8:559-65.
43. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161:1376-95.
44. Ordway D, Viveiros M, Leandro C, Amaral L. Chlorpromazine and thioridazine have intracellular killing activity against phagocytosed multi-drug resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47:917-22.
45. Silveira HD, Ordway D, Dockrell H, Jackson M, Ventura F. Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol 1997; 110:26-34.
46. Harries AD, Nyirenda TE, Banerjee A, Boeree MJ, Salaniponi FM. Tuberculosis in health care workers in Malawi. Trans R Soc Trop Med Hyg 1999; 93:32-5.
47. Kanyerere HS, Salaniponi FM. Tuberculosis in health care workers in a central hospital in Malawi. Int J Tuberc Lung Dis 2003; 7:489-92.
48. Direccao-Geral da Saude. Programa Nacional de Controlo da Tuberculose. Ponto da situacao epidemiologica e desempenho. Lisbon: Direccao-Geral da Saude, 2002; 1-9.
49. + T-cell memory determined by clonal burst size. Nature 1994; 369:652-4.
50. + T cell effector function in response to an intracellular pathogen. J Immunol 2004; 172:130-7.
51. Junqueira-Kipnis AP, Turner J, Gonzalez-Juarrero M, Turner OC, Orme IM. Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis. Infect Immun 2004; 72:570-5.
52. + T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages. Eur J Immunol 2003; 33:3293-302.
53. De La Barrera SS, Finiaz M, Frias A, et al. Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis. Clin Exp Immunol 2003; 132:450-61.
54. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. J Immunol 1995; 154:1786-96.
55. Boom WH. Gamma delta T cells and Mycobacterium tuberculosis. Microbes Infect 1999; 1:187-95.
56. Thoma-Uszynski S, Stenger S, Modlin RL. CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J Immunol 2000; 165:5773-9.
57. Dieli F, Troye-Blomberg M, Ivanyi J, et al. Granulysin-dependant killing of intracellular and extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T lymphocytes. J Infect Dis 2001; 184:1082-5.
58. Rook GAW. Advances in the immunopathogenesis of pulmonary tuberculosis. Curr Opin Pulm Med 2001; 7:116-23.
59. Seah GT, Rook GA. High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction: correlates with serum IgE levels. Scand J Infect Dis 2001; 33:106-9.
60. Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181:385-9.
61. Fine PM, Stern JAC, Ponnighaus JM, Rees RJW. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994; 344:1245-9.
62. Szereday L, Baliko Z, Szekeres-Bartho J. γ/δT cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy. Clin Exp Immunol 2003; 131:287-91.
63. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.
64. Al Zahrani KH, Al Jahdali H, Menzies D. Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial diseases. Am J Respir Crit Care Med 2000; 162:1419-22.
65. Baliko Z, Szereday L, Szekeres-Bartho J. Th2 biased response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy. FEMS Immunol Med Microbiol 1998; 22:199-20.4